1-Methyl-4-(prop-1-en-2-yl)benzene
Common Name: |
1-Methyl-4-(prop-1-en-2-yl)benzene |
IUPAC Name: |
1-methyl-4-prop-1-en-2-ylbenzene |
Molecular Formula: |
C10H12 |
SMILES: |
CC1=CC=C(C=C1)C(=C)C |
Inchi: |
1S/C10H12/c1-8(2)10-6-4-9(3)5-7-10/h4-7H,1H2,2-3H3 |
Inchi Key: |
MMSLOZQEMPDGPI-UHFFFAOYSA-N |
Cas No: |
1195-32-0 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
132.20 |
Mass (g/mol) |
132.094 |
Molar Refractivity |
46.31 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
0.00 |
Hetero Atoms |
0 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
-20 |
Boiling Point (°C@760.00mm Hg) |
186.00 to 189.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.834 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.20 |
LogP |
3.028 |
iLOGP |
2.43 |
XLOGP3 |
3.69 |
WLOGP |
3.03 |
MLOGP |
4.38 |
ESOL Log S |
-3.36 |
ESOL Solubility (mg/ml) |
0.057 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.38 |
Ali Solubility (mg/ml) |
0.06 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.58 |
Silicos-IT Solubility (mg/ml) |
0.03 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.49 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.738 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.699 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |